Viewing Study NCT01051557


Ignite Creation Date: 2025-12-24 @ 6:49 PM
Ignite Modification Date: 2025-12-26 @ 11:09 AM
Study NCT ID: NCT01051557
Status: COMPLETED
Last Update Posted: 2021-07-19
First Post: 2010-01-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Anaplastic Astrocytoma View
None Adult Anaplastic Oligodendroglioma View
None Adult Diffuse Astrocytoma View
None Adult Giant Cell Glioblastoma View
None Adult Glioblastoma View
None Adult Gliosarcoma View
None Adult Mixed Glioma View
None Adult Oligodendroglioma View
None Recurrent Adult Brain Neoplasm View
Keywords: